Search
for
Sort by
Research 121–150 of 1000+
- Follicular Unit Extraction (FUE) Hair Transplantation
- Madarosis, milphosis, eyelash trichomegaly, and dermatochalasis
- Baricitinib Effectiveness and Patient Impressions in Routine Clinical Practice: 12-month Results from a Prospective Observational Real-world Study
- Clinical course of the first Japanese family with Marie Unna hereditary hypotrichosis: a follow-up report
- Alopecia
- Trichostasis spinulosa of the scalp mimicking Alopecia Areata black dots
- Alopecia areata multiplex following autologous dermal micrograft injection for treatment of androgenetic alopecia
- Clinico-epidemiological study of alopecia areata
- Recurring Chemotherapy-Associated Alopecia Areata: Case Report and Literature Review
- Oral abrocitinib for treatment of refractory alopecia areata: A retrospective study
- Coexistence of Alopecia Areata, Lichen Planopilaris, and Lichen Planus Pigmentosus: A Case Report
- Treatment of moderate-to-severe alopecia areata in adolescents with baricitinib: A retrospective review of 29 patients
- A case of multiple trichoepitheliomas associated with alopecia areata and systemic lupus erythematosus
- Alopecia areata masquerading as frontal fibrosing alopecia
- Alopecia areata in a patient receiving infliximab
- A puzzling Presentation of Alopecia Areata: Sudden-Onset Whitening of Hair and its Spontaneous Resolution
- Biologic: A Double Edged Sword - A Case of Etanercept Induced Alopecia Areata in a Patient with Psoriasis Vulgaris
- Alopecia Areata: An Evidence-Based Treatment Update
- Effectiveness and safety of Baricitinib in alopecia areata: a prospective cohort study
- Upadacitinib in the treatment of a patient with the triad of atopic dermatitis, vitiligo, and alopecia areata: a case report and literature review
- Current Treatment of Alopecia Areata
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- Imipramine-lnduced Alopecia Areata-like Lesions
- Switching JAK inhibitors: evaluating baricitinib’s effectiveness in alopecia areata after tofacitinib failure
- Ritlecitinib Efficacy in Adolescents With Alopecia Areata: A Real‐World Experience
- Defining a Therapeutic Window of Opportunity in Alopecia Areata: Predictors of Early Response to Baricitinib
- Criteria for Commencing and Continuing Subsidised Janus Kinase Inhibitor Therapy in Australian Alopecia Areata Patients—Results From an Australian Expert Consensus Exercise
- Efficacy and Safety of Long‐Term Azathioprine Therapy for Severe Alopecia Areata: A 10‐Year Cohort Study
- Real-life effectiveness and safety of baricitinib in 17 Japanese patients with alopecia areata: a 60-week single center study
- Demographics and Disease Characteristics of Patients with Alopecia Areata with Comorbid Atopic Dermatitis, Vitiligo or Anxiety/Depression: TARGET-DERM AA